Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

dual tasking

- PMLiVE

How innovation in healthcare is helping to drive behaviour change

By Ross Taylor

- PMLiVE

Balance between remote and in-person communications with HCPs

By Derek Annan

- PMLiVE

People buy people: mergers and acquisitions in medical communications

By Liz Jackson

- PMLiVE

Moving beyond vanilla to improve patient diversity in clinical trials

By Stephen O’Farrell

- PMLiVE

Can the patient pathway provide a route to success?

Why pharma companies need to identify barriers and co-create solutions along the patient pathway to ensure their new products reach the patients who need them

- PMLiVE

Novartis to acquire Chinook Therapeutics for approximately $3.5bn

The deal marks a notable expansion to the Swiss drugmaker's kidney disease pipeline

Biogen Idec building

Biogen/Eisai’s Alzheimer’s drug backed by FDA advisory committee for traditional approval

Leqembi was granted accelerated approval by the FDA in January for patients with early AD

- PMLiVE

AstraZeneca and Quell announce autoimmune disease partnership worth over $2bn

The collaboration will initially focus on developing cell therapies for type 1 diabetes and IBD

- PMLiVE

Mental health in the workplace: an outdated concept?

By Laura Glover

- PMLiVE

Inequality, inequity, disparity…

By Tim Cockroft

- PMLiVE

Improving remote communication skills in a digital environment

By Niamh Mangan

- PMLiVE

Intersectional health equity starts with diversity in clinical trials

By Jessica Pacey

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links